CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
Clinical trial NCT05257590 · RECRUITING
Trial details
- NCT number
- NCT05257590
- Sponsor
- TaiRx, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2026-12-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.